Nektar Therapeutics is a leading biopharma company developing clinical stage products based upon its advanced polymer conjugate chemistry technology. Read the full story

Seattle Genetics becomes a biotech partner of Genmab for developing antibody-drug conjugate (ADC). Read the full story

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced. Read the full story

Novartis has entered into a biotech partnering agreement with a division of Google to in-license its "smart lens" technology for all ocular medical uses. Read the full story

Discovery, preclinical and clinical stage pharma and biotech partnering forms a critical part of the drug candidate commercialization process. Read the full story

EPIRUS and Orygen Biotecnologia announced a broad biotech partnering collaboration for the development, manufacture and commercialization of multiple biotechnology products in Brazil. Read the full story

Proximagen Limited has entered into a preclinical biotech partnering agreement with Lundbeck, a big pharma company, to further its research program related to protein kinase inhibitors Read the full story

Exosome Diagnostics has entered into a biotech partnering agreement with Eli Lilly , the big pharma company, for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit Read the full story

Bristol-Myers Squibb Company and Samsung BioLogics have entered into a 10-year biotech partnering agreement under which Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its recently completed plant in Songdo Incheon, South Korea Read the full story

Astellas , a top 50 big pharma, entered into a biotech partnering with Ambrx  for the discovery and development of novel antibody drug conjugates. Read the full story